Evopoint Biosciences
PrivateLast Round
Series E
Feb 20, 2024
Est. Valuation
$752.3M
Total Funding Raised
$242.2M
Company Overview
Evopoint Biosciences is a biopharmaceutical company that develops therapies for oncology, infectious diseases, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evopoint Biosciences Comparables
Compare Evopoint Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Teligene | 66% | |
| Nodus Oncology | 54% | |
| Crystalys Therapeutics | 54% |
Evopoint Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 20, 2024 | ||||
| Series D | Dec 31, 2020 | ||||
| Series C | Aug 25, 2020 | ||||
| Series B | Jun 26, 2019 | ||||
| Series A | May 24, 2018 | ||||
Angel | Nov 1, 2017 |
Evopoint Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | Series E |
| Loyal Valley Capital | Series E, Series A, Series C |
| Agricultural Bank of China International | Series D |
| Jinan Industrial Development Investment Group | Series E |
| Chenhai Capital | Series E |
| Jiuyou Capital | Series D, Series C |
| Oceanpine Capital | Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2020
Led by Oceanpine Capital with participation from Agricultural Bank of China International.
- Aug 25, 2020
$145M round led by Loyal Valley Capital.
Evopoint Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evopoint Biosciences's valuation, stock price, and market status.
Is Evopoint Biosciences a public or private company?
Evopoint Biosciences is a private company.
What is the current stock price of Evopoint Biosciences?
Evopoint Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Evopoint Biosciences worth (valuation)?
Valuation information for Evopoint Biosciences is not publicly available.
Can I buy Evopoint Biosciences stock?
Evopoint Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evopoint Biosciences's last funding round?
Funding round information for Evopoint Biosciences is not publicly available.
Who are the main investors in Evopoint Biosciences?
Investor information for Evopoint Biosciences is not publicly disclosed.
Will Evopoint Biosciences IPO soon?
No public IPO plans have been announced for Evopoint Biosciences.
How can I track Evopoint Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evopoint Biosciences's secondary market activity and sign up for updates.